pharma news

News

NICE backs stomach cancer, PAH drugs for NHS use

AZ's Imfinzi is the first NHS immunotherapy for a form of stomach cancer, while MSD's Winrevair gets a green light for rare respiratory disease PAH.

News

Anthropic joins Gates Foundation on $200m health AI pledge

Anthropic and the Gates Foundation's initiative will close a gap in access to AI tools between high- and lower-income countries.

News

Trial miss doesn't dent Biogen's faith in Alzheimer's drug

Biogen will advance its tau-targeting Alzheimer's disease drug diranersen into phase 3, even though it missed the main endpoint in a midstage trial.

News

UK Health Secretary resigns, sparking leadership speculation

UK Health Secretary Wes Streeting has resigned from Keir Starmer's government, saying he has lost faith in the Prime Minister's leadership.

News

Regenxbio's Duchenne gene therapy clears phase 3 hurdle

Regenxbio is pitching at FDA approval in 2027 for its Duchenne muscular dystrophy gene therapy RGX-202, a potential rival to Sarepta/Roche's Elevidys.

News

FDA hands BeOne, Taiho approvals for blood cancers

BeOne gets the nod for BCL2 inhibitor Beqalzi in mantle cell lymphoma, while Taiho's Inqovi has acute myeloid leukaemia added to its label.

NICE backs stomach cancer, PAH drugs for NHS use

Anthropic joins Gates Foundation on $200m health AI pledge

Trial miss doesn't dent Biogen's faith in Alzheimer's drug

UK Health Secretary resigns, sparking leadership speculation

Regenxbio's Duchenne gene therapy clears phase 3 hurdle

FDA hands BeOne, Taiho approvals for blood cancers

Europe is facing a surge in STIs, says ECDC

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks